Evidence map›Paper›PMID 35308203›Full record

ArticleFrontiers in pharmacology2022

A Retrospective Metabolomics Analysis of Gamma-Hydroxybutyrate in Humans: New Potential Markers and Changes in Metabolism Related to GHB Consumption.

Tingting Wang, Kirstine L Nielsen, Kim Frisch, Johan K Lassen, Camilla B Nielsen, Charlotte U Andersen, Palle Villesen, Mette F Andreasen, Jørgen B Hasselstrøm, Mogens Johannsen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Tingting WangDepartment of Forensic Medicine, Section for Forensic Chemistry, Aarhus University, Aarhus, Denmark.
Kirstine L NielsenDepartment of Forensic Medicine, Section for Forensic Chemistry, Aarhus University, Aarhus, Denmark.
Kim FrischDepartment of Forensic Medicine, Section for Forensic Chemistry, Aarhus University, Aarhus, Denmark.
Johan K LassenBioinformatics Research Centre, Aarhus University, Aarhus, Denmark.
Camilla B NielsenDepartment of Forensic Medicine, Section for Forensic Chemistry, Aarhus University, Aarhus, Denmark.
Charlotte U AndersenDepartment of Forensic Medicine, Section for Forensic Chemistry, Aarhus University, Aarhus, Denmark.
Palle VillesenBioinformatics Research Centre, Aarhus University, Aarhus, Denmark.
Mette F AndreasenDepartment of Forensic Medicine, Section for Forensic Chemistry, Aarhus University, Aarhus, Denmark.
Jørgen B HasselstrømDepartment of Forensic Medicine, Section for Forensic Chemistry, Aarhus University, Aarhus, Denmark.
Mogens JohannsenDepartment of Forensic Medicine, Section for Forensic Chemistry, Aarhus University, Aarhus, Denmark.
Aarhus University · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

GHB is an endogenous short-chain organic acid presumably also widely applied as a rape and knock out drug in cases of drug-facilitated crimes or sexual assaults (DFSA). Due to the endogenous nature of GHB and its fast metabolism

Indexed as

biomaker discoverydriving under the influence of drugs (DUID)drug metabolismGamma-hydroxybutyratemetabolomicsretrospective studyUPLC-QTOF analysiswhole blood samples

Identifiers

PMID35308203
PMCPMC8927817
OpenAlexW4214812725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.